61 Live Notices for Tamsulosin Tenders
Showing 1 to 20
Supply Of Hypolychants Medicines Antiep
08 Feb 2025
17 Feb 2025Dutasteride 500 mcg + Tamsulosin hydrochloride 400 mcg capsule, hard 132,000 tablets
6505--Tamsulosin Capsules
Object: Electronic Auction - Registration Of Prices For Future And Eventual Acquisition Of Medicines, To Replenish The Stock Of The Municipal Specialized Pharmacy, In Order To Serve Users Of The Unified Health System Of The Public Network Of The Municipality Of Angra Dos Reis.
6505--Tamsulosin Capsules
Supply Agreement For Medicines With Tablets Ges 2025-2027
Tender For The Purchase Of Dutasteride 500 Mcg + Tamsulosin Hydrochloride 400 Mcg Modified-Release Capsule, Hard By Electronic Bidding.
Completion Of A Non-Excl. Discount Agreement According To § 130A Paragraph 8 Sgb V For Solifenacin And Tamsulosin, Atc Code: G04Ca53 For The Period From September 1St, 2023 To August 31St, 2025
Conclusion Of Non-Exclusive Discount Agreements In Accordance With §§ 130A Paragraph 8/130C Paragraph 1 Sgb V For Drugs With The Active Ingredients Tamsulosin And Dutasteride (G04Ca52) As Part Of A So-Called Open House Model.
Conclusion Of Non-Exclusive Discount Agreements In Accordance With §§ 130A Paragraph 8/130C Paragraph 1 Sgb V For Drugs With The Active Ingredients Tamsulosin And Dutasteride (G04Ca52) As Part Of A So-Called Open House Model.
Drugs With The Active Ingredient Combination Tamsulosin And Dutasteride (Atc: G04Ca52)
Open House Discount Drug Contracts Tamsulosin And Dutasteride, Atc G04Ca52
Open House Contracts For Multiple Active Ingredients/Active Ingredient Combinations
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With § 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Combination Of Dutasteride And Tamsulosin Atc Code: G04Ca52
Conclusion Of A Non-Exclusive Discount Agreement According To § 130A Para. 8 Sgb V For The Active Ingredient Tamsulosin + Solifenacin, Atc G04Ca53 For The Period May 1St, 2023 - April 30Th, 2025
Conclusion Of A Non-Exclusive Discount Agreement According To § 130A Para. 8 Sgb V For The Active Ingredient Tamsulosin + Solifenacin, Atc G04Ca53 For The Period May 1St, 2023 - April 30Th, 2025
Conclusion Of Non-Exclusive Drug Discount Agreements According To § 130A Para. 8 Sgb V By Means Of A So-Called Open House Model For The Active Ingredient Tamsulosin/Dutasteride (Atc Code Who: G04Ca52)
Tamsulosin Og Solifenacin Tabl. M Modif Udløsn Ba1.12.B
Tamsulosin Kaps. M. Modif. Udl. Ba1.12.B
Bidding For The Purchase Of 3 Drug Items: Silodosin 4 Mg Tablet, Tamsulosin Hcl 0.4 Mg Sr Tablet And Oxybutynin 5 Mg Tablet By Electronic Bidding Method.
Tenders by Country